Australia is eagerly awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://esmeeuiyw325465.mycoolwiki.com/8931430/this_new_drug_retatrutide_australia_a_new_hope_for_losing_weight